FOXP3 and cancer: Such a favorable role of immunosuppressive Foxp3+ T cell depletion was demonstrated previously in a mouse model of mammary carcinoma where reduced immunosuppressive activity significantly affected tumor progression through increased cancer cell death and improved overall survival [37].